Why did Ian leave Pfizer?
Rachel Hunter While Read was CEO, Pfizer scored 30 FDA approvals and returned $120 billion to shareholders, the company said when he stepped down. Dividends grew, and Read left the company with a “strong pipeline” with the potential for up to 30 approvals through 2022.
How long was Ian Read CEO of Pfizer?
During his 10-year run as Pfizer’s CEO, he pulled off several major transactions, including the $14 billion buyout of Medivation in 2016 that gave the company blockbuster prostate cancer drug Xtandi.
Who was Pfizer CEO before Ian read?
Albert Bourla, Pfizer’s chief operating officer, will take over as chief executive effective on that date. Before becoming COO, Dr Bourla led the company’s Innovative Health unit. Mr Read is a 25-year veteran of the company and became chief executive in December 2010. He took up the chairmanship a year later.
Did Pfizer CEO retire?
Also an executive vice president, MacKenzie will retire from his post in 2022 after a 35-year career at the Big Pharma. …
How much does Albert Bourla make?
As the Chairman of the Board and Chief Executive Officer of Pfizer, the total compensation of Albert Bourla at Pfizer is $17,929,000. There are no executives at Pfizer getting paid more.
Who was the CEO before Albert Bourla?
He was succeeded as CEO by Albert Bourla on 1 January 2019, becoming executive chairman….
| Ian Read | |
|---|---|
| Board member of | Pfizer Kimberly-Clark |
Who is the founder of Pfizer?
Charles Pfizer
Charles F. Erhart
Pfizer/Founders
Who was the last CEO of Pfizer?
Jeffrey B. Kindler (born May 13, 1955) is an American healthcare executive and private investor. He served as chairman and CEO of the pharmaceutical company Pfizer from 2006 to 2010. Kindler has later served as CEO of Centrexion Inc., and chairman of the GLG Institute.
Who is the chairman of the board of Pfizer?
Albert Bourla
| Albert Bourla | |
|---|---|
| Employer | Pfizer |
| Title | Chairman and CEO of Pfizer |
| Board member of | Biotechnology Innovation Organization Catalyst Partnership for New York City Pfizer Pfizer Foundation Pharmaceutical Research and Manufacturers of America |
| Spouse(s) | Myriam Alchanati |
What is the salary of Pfizer CEO?
Pfizer Inc. paid Chief Executive Officer Albert Bourla $21 million in total compensation last year, as the pharmaceutical giant became the first to gain U.S. authorization for a coronavirus vaccine.
Who is the CEO of Pfizer Canada?
He joined the company in 1993 and has held several executive roles across Pfizer’s divisions….
| Albert Bourla | |
|---|---|
| Employer | Pfizer |
| Title | Chairman and CEO of Pfizer |
When did Ian Read become CEO of Pfizer?
Ian Read was named CEO of Pfizer on December 6, 2010, and Chairman of its Board of Directors on December 12, 2011. Since Mr. Read assumed the CEO role in 2010, Pfizer has recorded several achievements: Total shareholder return of 250%, outperforming the S&P 500 index by 180 percentage points
Who is the CEO of Pfizer 2019?
Jump to navigation Jump to search. Ian C. Read (born 1953) is a Scottish-born American business executive, a chartered accountant, serving as executive chairman of pharmaceutical giant Pfizer. He was succeeded as CEO by Albert Bourla on 1 January 2019, becoming executive chairman.
How does Pfizer make most of its money?
Pfizer has a tendency to make most of its money by increasing the cost of drugs that are already in production. When he took over as CEO, this was something the company was worried about because it creates a great deal of backlash within the general public. Under his direction, the company has continued to increase its prices more than ever.
Where did Ian reads grow up?
Read was born in Forfar, Scotland, to a Scottish mother, but his parents returned to Rhodesia (now Zimbabwe) when he was six-weeks-old, and he grew up there.
